ArticleInternational journal of clinical oncology2021

Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up.

Rihito Aizawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.